ArticleClinical, cosmetic and investigational dermatology2026
A
Article in Clinical, cosmetic and investigational dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study investigates whether Methods: Natural senescent human foreskin fibroblasts (BJ) were treated with varying concentrations of GLE, and safe concentrations were determined using the cell counting kit-8 (CCK-8) assay. The levels of mitochondrial reactive oxygen species (ROS) and mitochondrial membrane potential (MMP) were measured. Animal experiments were conducted to validate GLE's effects on wound healing by assessing adenosine triphosphate (ATP) and ROS levels in skin tissues. Results: GLE exhibited no cytotoxicity within a concentration range of 0-100 µg/mL. Simultaneously treating senescent BJ cells with 50 µg/mL or 100 µg/mL of GLE can significantly enhance cell viability. Treatment with 100 µg/mL GLE significantly increased MMP levels while reducing mitochondrial ROS levels. Hydrogel containing 2% GLE applied to injured skin promoted wound healing, increased the ATP level of the wound tissue, and decreased ROS levels in skin tissues. Conclusion: These findings suggest that GLE can improve mitochondrial function in aging skin and promote wound healing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.